BIRC5 and breast carcinoma: Finally, survivin depletion-mediated X-linked inhibitor of apoptosis (XIAP) degradation had been shown to contribute to the effects of YM155 against breast cancer cells.34 However, survivin depletion did not decrease XIAP levels in our models (Figures 2 and 5).